Ling Yang, Zhaoyang Ye, Linsheng Li, Li Zhuang, Jingzhi Guan, Wenping Gong
{"title":"利用文献计量学对肺癌和肺结核并存的研究进展和趋势进行可视化分析","authors":"Ling Yang, Zhaoyang Ye, Linsheng Li, Li Zhuang, Jingzhi Guan, Wenping Gong","doi":"10.1002/med4.58","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>The incidence of lung cancer combined with pulmonary tuberculosis has been increasing, but there is relatively limited published literature on the topic of lung cancer combined with tuberculosis (LC-PTB) from a bibliometric perspective. Therefore, in this study, we aimed to quantitatively analyze the LC-PTB-related literature to better understand the current status of this field and identify future research trends.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We searched for articles related to LC-PTB using the Web of Science Core Collection (SCI-E) and conducted a visual analysis of publication quantity, countries, institutions, authors, journals, references, and keywords using bibliometric software (CiteSpace, VOSviewer, and Scimago Graphica).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>As of January 8, 2024, a total of 460 publications related to LC-PTB were included for analysis from 3705 retrieved records. The number of publications has been increasing almost yearly, with most from China (<i>n</i> = 123), followed by the United States (<i>n</i> = 77). Taipei Medical University contributed the most publications (<i>n</i> = 11). Jing-Yang Huang and Yung-Po Liaw (eight documents each) ranked first among the included authors. The <i>Journal of Thoracic Oncology</i> was the most productive academic journal on LC-PTB. The aggregation of key nodes in the co-citation network and the chronological sequence indicated that LC-PTB research has shifted from initial hotspots such as lung diseases, bronchitis, and exposure to recent areas, including immunotherapy, immune checkpoint inhibitors, and nivolumab.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>In this study, we visualized the current status of LC-PTB research as well as future trends using bibliometric methods, providing new insights into the differential diagnosis of LC-PTB and its related promoting mechanisms.</p>\n </section>\n </div>","PeriodicalId":100913,"journal":{"name":"Medicine Advances","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/med4.58","citationCount":"0","resultStr":"{\"title\":\"Visualization analysis of research progress and trends in coexistence of lung cancer and pulmonary tuberculosis using bibliometrics\",\"authors\":\"Ling Yang, Zhaoyang Ye, Linsheng Li, Li Zhuang, Jingzhi Guan, Wenping Gong\",\"doi\":\"10.1002/med4.58\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>The incidence of lung cancer combined with pulmonary tuberculosis has been increasing, but there is relatively limited published literature on the topic of lung cancer combined with tuberculosis (LC-PTB) from a bibliometric perspective. Therefore, in this study, we aimed to quantitatively analyze the LC-PTB-related literature to better understand the current status of this field and identify future research trends.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>We searched for articles related to LC-PTB using the Web of Science Core Collection (SCI-E) and conducted a visual analysis of publication quantity, countries, institutions, authors, journals, references, and keywords using bibliometric software (CiteSpace, VOSviewer, and Scimago Graphica).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>As of January 8, 2024, a total of 460 publications related to LC-PTB were included for analysis from 3705 retrieved records. The number of publications has been increasing almost yearly, with most from China (<i>n</i> = 123), followed by the United States (<i>n</i> = 77). Taipei Medical University contributed the most publications (<i>n</i> = 11). Jing-Yang Huang and Yung-Po Liaw (eight documents each) ranked first among the included authors. The <i>Journal of Thoracic Oncology</i> was the most productive academic journal on LC-PTB. The aggregation of key nodes in the co-citation network and the chronological sequence indicated that LC-PTB research has shifted from initial hotspots such as lung diseases, bronchitis, and exposure to recent areas, including immunotherapy, immune checkpoint inhibitors, and nivolumab.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>In this study, we visualized the current status of LC-PTB research as well as future trends using bibliometric methods, providing new insights into the differential diagnosis of LC-PTB and its related promoting mechanisms.</p>\\n </section>\\n </div>\",\"PeriodicalId\":100913,\"journal\":{\"name\":\"Medicine Advances\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/med4.58\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicine Advances\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/med4.58\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine Advances","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/med4.58","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
肺癌合并肺结核的发病率一直在上升,但从文献计量学的角度来看,有关肺癌合并肺结核(LC-PTB)的发表文献相对有限。因此,在本研究中,我们旨在对肺癌合并肺结核相关文献进行定量分析,以更好地了解该领域的现状并确定未来的研究趋势。我们使用 Web of Science Core Collection(SCI-E)检索了与 LC-PTB 相关的文章,并使用文献计量软件(CiteSpace、VOSviewer 和 Scimago Graphica)对发表数量、国家、机构、作者、期刊、参考文献和关键词进行了可视化分析。论文数量几乎每年都在增加,其中来自中国的论文最多(123 篇),其次是美国(77 篇)。台北医学大学发表的论文最多(11 篇)。黄景阳和廖永波(各8篇)在收录作者中排名第一。胸部肿瘤学杂志》是发表 LC-PTB 论文最多的学术期刊。共引网络中关键节点的聚集和时间顺序表明,LC-PTB研究已从最初的热点领域,如肺部疾病、支气管炎、暴露等,转移到近期的免疫疗法、免疫检查点抑制剂、nivolumab等领域。
Visualization analysis of research progress and trends in coexistence of lung cancer and pulmonary tuberculosis using bibliometrics
Background
The incidence of lung cancer combined with pulmonary tuberculosis has been increasing, but there is relatively limited published literature on the topic of lung cancer combined with tuberculosis (LC-PTB) from a bibliometric perspective. Therefore, in this study, we aimed to quantitatively analyze the LC-PTB-related literature to better understand the current status of this field and identify future research trends.
Methods
We searched for articles related to LC-PTB using the Web of Science Core Collection (SCI-E) and conducted a visual analysis of publication quantity, countries, institutions, authors, journals, references, and keywords using bibliometric software (CiteSpace, VOSviewer, and Scimago Graphica).
Results
As of January 8, 2024, a total of 460 publications related to LC-PTB were included for analysis from 3705 retrieved records. The number of publications has been increasing almost yearly, with most from China (n = 123), followed by the United States (n = 77). Taipei Medical University contributed the most publications (n = 11). Jing-Yang Huang and Yung-Po Liaw (eight documents each) ranked first among the included authors. The Journal of Thoracic Oncology was the most productive academic journal on LC-PTB. The aggregation of key nodes in the co-citation network and the chronological sequence indicated that LC-PTB research has shifted from initial hotspots such as lung diseases, bronchitis, and exposure to recent areas, including immunotherapy, immune checkpoint inhibitors, and nivolumab.
Conclusion
In this study, we visualized the current status of LC-PTB research as well as future trends using bibliometric methods, providing new insights into the differential diagnosis of LC-PTB and its related promoting mechanisms.